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Abstract
Cancer is a complex disease wherein mutations in protein-encoding genes lead to numerous tempo-spatial changes in cell physiology, ultimately 
leading to malignant tumors. Indian Population Based Cancer Registries documents incidences of cancers across the country and it was reported that 
highest Age Adjusted Rates was found in cancers of the tongue, hypopharynx and oesophagus which are head and neck cancers. They are amongst the 
commonest malignancies, accounting for approximately 20% of the cancer burden in India, tobacco and alcohol are the two major risk factors. Common 
acute reactions experienced during radiotherapy are dysgeusia and fatigue, which may cause cancer cachexia. These patients have one of the highest 
malnutrition prevalence rates, which affects physical function and quality of life with 25-50% of these patients classified as nutritionally compromised prior to 
commencement of treatment. Minimizing weight loss for patients at nutritional risk is a major goal of nutritional management. It is important to replenish the 
protein and energy intakes along with the micronutrients. Common nutrition goals for surgical patients include symptoms management, weight maintenance, 
preservation of functional status and body composition which can be attained by modulation of dietary components, addition of oral nutritional supplements, or 
provision of enteral or parenteral nutrition. Recent studies have shown that Enteral nutrition support via percutaneous endoscopic gastrostomy administered 
to the patients help in preventing weight loss, dehydration, nutrient deficiencies, treatment interruptions, hospitalizations and improving quality of life. 
Successful management of these patients requires orderly care and follow-up by a multidisciplinary nutrition team.
Keywords: Head and Neck Cancer; Quality of life; Malnutrition; Nutrition care
Nutrition; UICC: Union for International Cancer Control; UV: 
Ultraviolet; WHO: World Health Organization
Introduction
Cancer is a complex disease involving abnormal cell growth 
(neoplasia) and numerous tempo-spatial changes in cell physiology, 
which ultimately lead to malignant tumors. Tumor cells are invasive 
in nature which spread to the surrounding tissues and distant 
organs causing high rates of morbidity and mortality [1]. These 
altered cells no longer require special signals to induce cell growth 
and division as the processes regulating normal cell division are 
disrupted. Abnormalities such as change in cell structure, decreased 
cell adhesion, and production of new enzymes in cancer cells usually 
result from mutations in protein-encoding genes that regulate cell 
division [2]. The development of cancer is a multistep process that 
occurs in three stages: initiation, promotion, and progression [3]. 
The biological process by which normal cells are transformed into 
malignant cancer cells has been the subject of a large research effort 
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in the biomedical sciences for many decades. Malnutrition in cancer 
patients, also known as Cancer cachexia is due to cytokine-induced 
metabolic derangements. Patients with HNC have one of the highest 
malnutrition prevalence rates among all diagnostic groups, with 
25-50% of these patients classified as nutritionally compromised 
prior to commencement of treatment. Oncological therapies such 
as Radiotherapy and Chemotherapy further worsen the nutritional 
status of cancer patients, thereby making nutrition an important 
component of medical care. Weight loss during radiation therapy to 
the head and neck can diminish the safety and effectiveness of the 
treatment. Impaired nutritional status is associated with decreased 
QoL, physical function, and survival and therefore, with increased 
personal, social and healthcare costs [4]. Because of the complex, 
multifactorial nature of disease-related malnutrition, it is often 
very challenging to conduct high-level clinical nutrition studies. In 
India, literature on nutrition screening and the impact of nutrition 
interventions in cancer patients is limited. Commercially available 
formulations are high in cost and are not disease specific; therefore 
there is a need to formulate a low cost food formulation using 
functional ingredients which could meet the nutritional needs and 
reduce the financial burden of cancer patients in India. Since most of 
the patients with HNC are unable to take food orally, the formulation 
should be suitable both for oral and enteral feeding. Researchers are 
also focusing on medicinal plants with anti-cancer properties and its 
utilization as a nutraceuticals.
Types of Head and Neck Cancer (HNC)
The head and neck region comprises a variety of anatomic sites. 
HNC affects moist mucosal surfaces like the mouth, throat and nose. 
Tumors arising from the skin, nasal cavity and paranasal sinuses, oral 
cavity, nasopharynx, oropharynx, hypopharynx, larynx, esophagus, 
thyroid gland, salivary glands, soft-tissue tumors, bone sarcomas, and 
miscellaneous tumors such as neurogenic tumors and paragangliomas 
are all generically included in the head and neck region [5]. Laryngeal 
cancer includes tumors of the supraglottis, glottis and subglottis; 
Hypopharyngeal cancer affects postcricoid area, pyriform sinus and 
posterior pharyngeal wall; Oropharyngeal cancer affects the base of 
tongue, tonsil and soft palate; Oral cavity cancer includes tumors of 
the buccal mucosa, retromolar triangle, alveolus, hard palate, anterior 
two-thirds of tongue, floor of mouth and mucosal surface of the lip 
[6].
Causes and Risk Factors of HNC
The transformation from a normal cell into a tumor cell is a 
multistage process, typically a progression from a pre-cancerous 
lesion to malignant tumors. These changes are the result of the 
interaction between a person’s genetic factors and three categories of 
external agents, including: 
•	 physical	 carcinogens,	 such	 as	 ultraviolet	 and	 ionizing	
radiation; 
•	 chemical	 carcinogens,	 such	 as	 asbestos,	 components	 of	
tobacco smoke, aflatoxin (food contaminant) and arsenic 
(drinking water contaminant); and 
•	 biological	 carcinogens,	 such	 as	 infections	 from	 certain	
viruses, bacteria or parasites.
WHO, through its cancer research agency, IARC, maintains a 
classification of cancer causing agents [7].
Risk Factors of HNC
a. Viruses:  HNC associated with Human Papilloma Virus 
(HPV) infection is increasing. In a systematic review by Kreimer et 
al, 5046 cases of SCC were identified from 60 eligible studies from 26 
countries. These included 2,642 cases from the oral cavity, 969 cases 
from the oropharynx, and 1,435 cases from the larynx. Twenty-six 
percent of all HNSCC biopsy specimens were HPV positive. Overall 
HPV prevalence was significantly higher in oropharyngeal SCCs 
(35.6%) than in oral SCCs (23.5%) and laryngeal SCCs (24.0%). 
HPV16 was the most common type detected which was present in 
30.9% of oropharyngeal SCCs, 16.0% of oral SCCs, and 16.6% of 
laryngeal SCCs. HPV16 thus accounted for 86.7% of all HPV-positive 
oropharyngeal SCCs compared with 68.2% of HPV-positive oral 
SCCs and 69.2% of HPV-positive laryngeal SCCs. HPV18 was the 
next most common oncogenic HPV type detected and was detected 
in 8.0% and 3.9% of oral and laryngeal SCCs, respectively, yet was 
only present in 1.0% of oropharyngeal SCCs [8].
b. Tobacco: The relationship between cigarette smoking and 
regular exposure to tobacco smoke with various types of cancers is 
known. The use of other tobacco products, such as chewing tobacco, 
is linked to cancers of the mouth, tongue and throat. In a study, the 
effect of use of powdered tobacco (Khaini tobacco) with the addition 
of lime used by the residents of Bihar, India was studied. The tobacco/
lime mixture is usually placed on the inner side of the lower lip within 
the gingivolabial groove. Carcinomas (so-called “Khaini cancers”) 
develop mainly at the site where the tobacco is in close contact with 
the mucosa. The micronucleus test on exfoliated cells provided 
evidence of carcinogen exposure in the tissue from which cancer 
developed [9]. Epidemiologic studies suggest a strong association 
between smokeless tobacco and oral carcinogenesis. However, the 
risk of cancer decreases soon after a smoker quits, while precancerous 
conditions often diminish after a person stops using smokeless 
tobacco [4].
c. Alcohol: Heavy drinkers face an increased risk of cancers 
of the mouth, throat, esophagus, larynx and liver. Some studies 
suggest that even moderate drinking may slightly increase the risk 
of breast cancer. All cancers caused by cigarette smoking and heavy 
use of alcohol could be prevented completely. A case control study of 
combined effect of tobacco and alcohol on laryngeal cancer risk was 
studied which suggested that there was an increased multiplicative 
risk of cancer with use of cigarette smoking and alcohol intake 
[9,10]. HNC tends to be more common in males. The most notable 
modifiable risk factors for developing HNC include the use of tobacco 
and /or marijuana; and frequent heavy consumption of alcohol. Use 
of alcohol potentiates tobacco-related carcinogenesis which is also an 
independent risk factor [4].
d. Paan (betel quid):  Immigrants from Southeast Asia who 
use paan (betel quid) have increased risk of oral cancer [11]. Betel 
nut chewing is associated with oropharyngeal cancer. A long term 
usage of betel nut causes “betel chewer’s perleche,”consisting of 
fissures at the angles of the mouth produced by constant moistness 
INDIAN JOURNAL OF NUTRITION Asna Urooj
Citation: Namratha PK, Urooj A. Nutritional Implications In Head And Neck Cancer - A Review. Indian J Nutri. 2014;1(1): 103.
03
and maceration. A unique type of leukoplakia is seen in the gingival 
area. This can progress to SCC of the oral cavity and esophagus. The 
calcium hydroxide component and arecaidine have subsequently 
been shown to cause submucosal fibrosis, a precancerous oral lesion 
that has been associated with an increased incidence of SCC. It is also 
observed that betel nut acts synergistically with tobacco to produce 
oral cancer [12].
e. Diet: Dietary factors have a dual role to play both in 
enhancing or reducing the risk of cancer. Several nutritive and 
non-nutritive dietary constituents are reported to increase the risk 
of cancer. Consumption of maté, a tea-like beverage habitually 
consumed by South Americans, has been associated with an increased 
risk of cancers of the mouth, throat, esophagus and larynx [13]. 
Consumption of certain preserved or salted foods during childhood 
is a risk factor for nasopharyngeal cancer observed in elevated rates in 
natives of Southeast Asia, Artic region, the Arabs of North Africa and 
parts of the Middle East [14]. 
Dietary factors have a role in reducing the risk of cancer. 
Epidemiologic data suggest a protective role of dietary carotenoids 
and an inverse association between the consumption of fruits 
and vegetables and the incidence of HNC. The specific protective 
components in these foods remain to be elucidated [15].
f. Occupational exposure: Occupational exposure to wood 
dust is a risk factor for nasopharyngeal cancer [16]. Exposure to 
chemicals such as dyes, solvents, pesticides, polycyclic aromatic 
hydrocarbons, chlorine etc have been associated with oral and 
pharyngeal cancer; and formaldehyde, bleaches, varnishes, adhesives 
and biocides with nasopharyngeal cancer. Exposure to glass fibres, coal 
particles and asbestos were associated with risk of hypopharyngeal 
cancer [17].
g. Radiation exposure: Radiation to treat the first primary 
cancer during childhood have a 39 fold higher risk to develop second 
primary salivary gland cancer [18].
h. Oral health: Poor oral hygiene, periodontal disease, chronic 
candidiasis, HPV and herpes virus infections link statistically with 
cancer. Infections may trigger cell proliferation, inhibit apoptosis, 
interfere with cellular signaling mechanisms and up-regulate tumor 
promoters. In addition, several oral micro-organisms metabolize 
alcohol to carcinogenic acetaldehyde thus explaining the association 
between poor oral hygiene, alcohol consumption and carcinogenesis 
[19].
Thus, to reduce or prevent these risk factors, consuming a 
balanced diet that meets fruit and vegetable dietary recommendations, 
avoiding or limiting alcohol consumption, and avoiding smoking 
appear to decrease the risk of developing HNC [4].
Incidences of HNC in India and Worldwide
The NCRP of the ICMR documents incidences of cancers. 
A comparison of the AARs of Indian PBCRs with the AARs of 
International PBCRs from five different continents viz. Africa, Asia, 
Australia, Europe, North America and South America available on 
cancer incidence was reported by the NCRP for the period 2009 to 
2011. Two registries from each continent demonstrating the highest 
AAR had been taken for comparison with the top five AARs among 
Indian PBCRs for all sites and selected sites of cancer. It was observed 
that highest AAR was seen among the Black males (519.9) population 
of Detroit, Michigan State, USA, whereas in females (389.3) highest 
AAR was seen in Goiana, Brazil [20]. The incidence of HNC varies 
widely across the world. Regions of high HNC include much of 
Southern Asia and parts of Central and Southern Europe. High 
incidence rates were reported from developing nations like India, 
Pakistan, Bangladesh, Taiwan and Sri Lanka. While an increasing 
trend has been observed in Pakistan, Taiwan and Thailand, a 
decreasing trend is seen in Philippines and Sri Lanka. The most 
common age of occurrence of cancer in different parts of oral cavity 
is usually between 51-55 years in most countries. Tongue is the 
leading site among oral cancers in India. The next most common 
sites in Asian countries include the buccal mucosa and gingiva [21]. 
Worldwide HNC statistics indicate that there are 6,40,000 cases of 
HNC per year, resulting in approximately 3,50,000 deaths per year. 
Cancer of the oral cavity and pharynx are the most common type of 
HNC with approximately 4,80,000 cases per year and about 1,60,000 
cases of larynx per year [22]. HNC is the sixth most common cancer 
worldwide. 
HNCs are amongst the commonest malignancies, accounting 
for approximately 20% of the cancer burden in India. The major risk 
factors are tobacco chewing, smoking and alcohol consumption, 
which are all preventable. In India, Aizawl district had higher AARs 
in both males (273.4) and females (227.8) among the PBCRs. Indian 
PBCRs had highest AARs in cancers of the tongue, hypopharynx 
and oesophagus [20]. The incidences differed regionally with greater 
incidences of cancers of Mouth (12.3%) and Lung (8%) in Mumbai; 
Hypopharynx (8.4%) and Oesophagus (7.9%) in Bangalore; Stomach 
(9.2%) and Lung (8.9%) in Chennai, in males. An average of 22.76% of 
Breast cancer and 22.06% of Cervix cancer was observed in all regions 
in females [23]. According to a study, malignant cases in Bihar, India 
were common in males than in females with male: female ration of 
3.1:1.  This observed incidence patterns are a reminder of widespread 
unawareness, low healthcare utilization with virtually non-existent 
cancer programs [24].                  
In another study, an estimation of newer cancer cases by 2026, in 
India, was done by Neevan et al.  In India, in 2011, nearly 1,193,000 
new cancer cases were estimated with a higher load among females 
(603,500) than males (589,800). It was estimated that the total 
number of new cases might increase from 0.589 million in 2011 to 
0.934 million by 2026 in males and 0.603 to 0.935 million in females. 
When adjustments for increasing tobacco habits and increasing 
trends in many cancers are made, the estimates may further increase 
[25]. From these studies it can be observed that the cases of Head and 
Neck Cancers are increasing in India. 
Diagnosis and Staging of HNC
Routine physical examination, including a thorough oral 
examination, is the best way to detect HNCs before they become 
symptomatic. Definitive diagnosis usually requires a biopsy. 
Additional information can be obtained from a combination of 
imaging tests, such as Computed Tomography (CT), Magnetic 
Resonance Imaging (MRI) or Positron Emission Tomography 
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(PET), endoscopy and fine-needle aspiration of any neck mass [26]. 
Head and neck cancers are staged according to size (T) and site of 
the primary tumor, the presence of metastases in the cervical lymph 
nodes (N), and evidence of distant metastases (M). Staging usually 
requires imaging tests [26].
TNM is an anatomic staging system that describes the anatomic 
extent of the primary tumor, involvement of regional lymph nodes 
and distant metastasis.  Revisions to the TNM staging system have 
been based on natural history of tumors at various sites aided by 
advances in technology that have allowed clinicians to better assess 
the extent of tumors. The majority of mucosal HNCs are SCCs. 
Therefore, the TNM classification of the Union for International 
Cancer Control (UICC) and the American Joint Committee on 
Cancer (AJCC) for most mucosal anatomic sites is designed for SCC 
and minor salivary gland cancers. For many decades, the AJCC-UICC 
TNM staging system has been used for staging HNC worldwide 
and the sixth version is the latest. In current practice, information 
obtained from clinical examination and radiologic imaging is used to 
assign a clinical stage (cTNM), which is then used to stratify patients 
for selection of therapy and to report outcomes of treatment. If the 
patient undergoes surgical resection, the pathologic stage (pTNM) 
derived from histopathologic examination of the tumor and/or 
regional lymph nodes are useful in selecting postoperative adjuvant 
therapy and for prognosis [5].
Common Complications In HNC Patients
Swallowing problem
Cancer treatment can cause mouth and throat problems. 
Swallowing requires movement of the lips, tongue, palate, throat, 
larynx and oesophagus. Surgery or radiation therapy may render 
severe dysfunction of the base of the tongue, larynx and pharyngeal 
muscle causing different types of swallowing problems due to which 
highest rate of malnutrition is observed in HNC patients [27].
Treatment induced complications
Complications associated with radiotherapy of the head and neck 
region deleteriously affects the salivary glands, oral mucosa, bone, 
dentition, masticatory musculature and temporomandibular joints 
due to which clinical consequences such as mucositis, hyposalivation, 
taste loss, osteoradionecrosis, radiation caries, fibrosis and trismus 
occurs. Mucositis and taste loss are reversible consequences whereas 
hyposalivation is irreversible [28].
Most patients with head and neck carcinomas, treated with 
a curative intent, receive a dose between 50 and 70 Gy [28]. RT is 
generally given 5 times per week at the rate of 2 Gy per day for 6-7 
weeks. The associated complications and side effects escalate with 
time and continue to worsen beyond the completion of therapy.
Slow healing and infection are indirect complications of cancer 
treatment. Both chemotherapy and radiation therapy can stop 
cells from dividing and slow the healing process in the mouth. 
Chemotherapy associated symptoms include nausea, vomiting, 
constipation and mucositis. It may decrease the number of white 
blood cells and weaken the immune system thus, predisposing to 
infections [4,29].
Cancer Cachexia
The term cancer cachexia is derived from the Greek words kakos 
and hexis meaning poor condition. Cachexia has been defined as a 
syndrome characterized by the progressive loss of lean tissue and body 
fat, and losses are often in excess to that explained by the associated 
anorexia. There are often additional metabolic derangements, 
including anaemia, acute phase protein response and alterations 
in plasma lipid profile [30]. Weight loss due to starvation differs 
significantly from weight loss due to cancer cachexia. Loss of weight 
in cachexia is due to cytokine-induced metabolic derangements 
such as insulin resistance, increased lipolysis and increased protein 
turnover which leads to decreased appetite, weight loss, and 
metabolic alterations. Although there is no definitive method for 
diagnosing cancer cachexia, clinical signs of anorexia, muscle wasting 
and unintentional weight loss of 5% or more of body weight in 6 
months not due to mechanical obstruction, treatment, side effects are 
suggestive of cancer cachexia [31].
Weight loss
Weight loss due to obstruction, treatment, or/and side effects, that 
is expected to cease once treatment is ceased, should not be described 
as cachexia, but rather as due to inadequate dietary intake. The causes 
of weight loss in patients with HNC are multifactorial and may be 
due to reduced intake, treatment related or mechanical obstruction, 
or cachexia. Symptoms such as anorexia, depression, anxiety, fatigue, 
early satiety and pain can result in a decreased appetite and food intake. 
Cancer treatment may result in weight loss, for example surgery 
(malabsorption), radiotherapy (nausea, pain, diarrhea, mucositis), 
and chemotherapy (nausea, vomiting, constipation, mucositis). 
Appropriate nutrition support provided during radiotherapy can 
help to overcome some of the nutrition impact symptoms and help 
patients to maintain weight compared with standard practice where 
patients continued to lose weight during radiotherapy treatment [32].
Dose of radiation therapy Occurrence of side effects Side effects
< 10 Gy 1st week Mucositis and hyperkeratinization
10 - 20 Gy 2nd week
Erythema of the skin, 
pseudomembranous 
mucositis,   ulceration, 
microbial infection and 
atrophy of taste buds.
20-30 Gy 3rd week
Taste changes ,mucositis, 
decreased amylase secretion 
paralleled by acinar cell 
loss and decreased salivary 
flow and change in salivary 
composition
30-50 Gy Upto 3 months
Taste alterations, dermatitis, 
change in the oral microflora 
causing dental caries and 
significant reduction in salivary 
flow, thyroid dysfunction.
50-70Gy 3 – 6 months
Dysgeusia, Xerostomia, 
Fibrosis, Stenosis, Muscular 
atrophy, cranial neuropathy, 
Osteoradionecrosis
Table 1: Side effects associated with Radiation therapy at different doses 
[27,28].
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Nutritional Challenges Associated With HNC
The continuum of cancer survival includes treatment and recovery 
as well as living with advanced cancer. Each stage is associated with 
different needs and challenges for the patients, caregivers, and 
clinicians. Both cancer and the oncological therapies utilized for its 
treatment can have profound effects on an individual’s nutritional 
status, thereby making nutrition an important component of medical 
care [3].
Effect of Malnutrition on HNC
Patients with HNC have one of the highest malnutrition prevalence 
rates among all diagnostic groups, with 25-50% of these patients 
classified as nutritionally compromised prior to commencement of 
treatment [33]. Weight loss during radiation therapy to the head 
and neck can diminish the safety and effectiveness of the treatment. 
Significant amounts of weight loss can also affect the chemotherapy 
regimen, preventing the patient from receiving the optimal dosage. 
Involuntary weight loss greater than 5% in one month, or more than 
1-2% per week, is a reliable indicator of malnourishment. Despite 
awareness, malnutrition continues to contribute to significant 
morbidity during and after therapy and impedes aggressive 
intervention.  Because of the complex, multifactorial nature of disease-
related malnutrition, it is often very challenging to conduct high-
level clinical nutrition studies. However, patients demonstrate better 
physical function and QoL with nutritional intervention compared to 
the usual care [4]. Malnutrition may not be a nutritional risk factor 
for all cancer patients however, nutritional screening, assessment and 
monitoring are crucial to prevent or minimize the development of 
malnutrition at every stage of treatment.
Nutrition Impact Symptoms (NIS)
NIS in patients with HNC may be attributable to tumor itself 
or may be side effects of the cancer treatment. The factors most 
significantly associated with nutritional status include tumor stage, 
tumor location, time since diagnosis, dietary intake, and previous 
treatment [4].
NIS such as nausea, vomiting, diarrhea, constipation, pain, 
anxiety, oropharyngeal mucositis, dysgeusia, xerostomia and fatigue 
during radiotherapy compounded by the addition of chemotherapy 
with other multimodality therapies are generally associated with 
increased toxicity which may be experienced even as long as 12 months 
following commencement of therapy and have been associated with 
reductions of Quality of Life (QoL) [34]. Because of the expected 
toxicities, malnutrition in patients with HNC is a serious clinical 
concern [35]. Impaired nutritional status due to improper food intake 
is associated with decreased QoL, physical function, and survival and 
therefore, with increased personal, social and healthcare costs. The 
functions of eating and drinking play a large role in social activity 
and participation hence decreasing the QoL in HNC patients. A 
study suggests that QoL shows better outcome than clinical outcomes 
alone [4]. Patients with cancer cachexia reported alterations in the 
body image which negatively affected their self-esteem, relationships, 
spirituality, physical activity and social functioning [3]. 
Dysphagia
Swallowing function often deteriorates but then improves for as 
long as 12 months post-treatment. Swallowing function may stabilize 
with time but often remains poorer than prior to treatment. Studies 
show that severity of dysphagia in some patients with HNC is correlated 
with compromised QoL, depression, and anxiety. Anecdotal evidence 
suggests that some patients with HNC will require dietetic and speech 
pathology support for months after treatments and may not ever 
return to managing a normal diet without supplementation [4].
Nutritional Management of HNC
Goals of Nutritional management in HNC
Considering the treatment related and nutritional complications 
discussed earlier, the major goals of nutritional management should 
be maintenance of body weight, minimizing weight loss preventing 
or minimizing nutritional deficiencies, preserving muscle tissue, 
minimizing nutrition-impact symptoms such as decreased appetite, 
nausea, bowel function changes; and maximizing QoL. Appropriate 
dietary intake ameliorates treatment related side effects such as early 
satiety, fatigue and anorexia. Professional practice suggests it is 
easier to prevent or slow the malnutrition trajectory than to reverse 
chronic malnutrition. In weight-losing patients with inadequate 
dietary intake, nutrition support (dietary counseling with or without 
supplements) should be provided to improve or maintain nutritional 
status and QoL. Patients should be initiated with nutritional 
management on presentation, prior to treatment; to avoid nutritional 
depletion. All patients with HNC should be regarded as being “at 
risk” for nutritional deficiencies irrespective of their tumor stage. 
Unfortunately, because of the limited resources available for nutrition 
diagnosis and treatment, referral of high-nutritional-risk patients is 
not always done consistently in practice [4]. 
The primary nutritional goal of addressing inadequate oral intake 
in these patients is to increase dietary intake to a level sufficient to 
meet their requirement. In addition to providing adequate energy 
and protein intake to meet the requirements, other agents for limiting 
cachexia have been investigated, including eicosa pentanoic acid and 
other pharmacotherapies [4].
Prior to treatment, nutrition assessment should be conducted 
using a valid a reliable nutrition assessment tool, which will be 
useful to assess nutritional status, guide nutrition intervention, and 
monitor outcomes in patients with cancer. Appropriate nutritional 
management and physical recommendations before, during and after 
treatments should be implemented to ensure best patient care and 
optimal outcomes [4].
Nutrition screening
Nutrition screening helps in identifying the nutritional risks and 
needs to plan suitable nutrition support to the target group. Nutrition 
screening is effective only with a formal, systematic nutrition 
assessment in patients. Significant weight loss is suggestive of a poor 
prognosis and also associated with decreased physical function, QoL 
and treatment schedules. Maintaining adequate nutrition during 
treatment requires considerable commitment and motivation for 
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most patients. Patients without support at home to prompt feeding at 
regular intervals are more likely to find maintaining adequate intake 
difficult [35]. Malnutrition Screening Tool (MST) has been used in 
the cancer population to identify those patients who are at greatest 
risk for developing nutritional problems [36].
Nutrition Assessment tools in Common use
Very few validated tools have been available to assess the 
nutrition status in patients with cancer. The commonly used tools by 
researchers and clinicians are Malnutrition Screening Tool (MST), 
Subjective Global Assessment (SGA), Patient Generated- Subjective 
Global Assessment (PG-SGA), Nutrition Risk Index (NRI), Short 
Form-36 (SF-36) and The European Organization for Research 
and Treatment of Cancer questionnaire (EORTC); The Eastern 
Cooperative Oncology Group (ECOG) performance status scale to 
assess the functional status.
There are various tools used in assessing the nutritional and 
functional status of HNC patients:
According to the American Dietetic Association (ADA), an 
effective nutrition screening tool should be: 
•	Simple,	quick,	reliable,	valid	and	inexpensive	
•	Easily	administered	with	minimal	nutritional	expertise	
•	Applicable	 to	most	patients	and	designed	 to	 incorporate	only	
routine data and tests available on admission.
MST: It is a five step screening tool to evaluate adults, who are 
malnourished, at risk of malnutrition or obese. It also includes 
guidelines which can be used to develop a nutrition care plan [36].
PNI: Using parameters such as serum albumin, serum transferrin, 
triceps skin fold, and delayed hypersensitivity, the PNI was developed 
and is calculated as:
PNI%= 158% -16.6(ALB) - 0.78 (TSF) - 0.2(TFN) - 5.8 (DH) [37].
[ALB = albumin (g/dL); TSF = average of three triceps skin fold 
measurements (mm); TFN = serum transferrin (mg/dL); DH = number 
of positive delayed hypersensitivity responses measured at 24 and 48 
hours after intradermal injection of five antigens (Candida albicans, 
mumps, tuberculin purified protein derivative, Trichophyton, and 
streptokinase-streptodornase). Major post-operative complications 
occurred in patients with a PNI > 20. In another study, a PNI > 40 
indicated a high risk of developing a post-operative infection]. 
NRI:  It uses parameters such as serum albumin concentration 
and the ratio of actual to usual weight and was originally developed in 
AIDS and cancer patients [38,39]. The NRI formula is calculated as: 
NRI = (1.519 × serum albumin, g/dL) + {41.7 × present weight 
(kg)/usual body weight(kg)} [40]. [From these NRI values, four 
grades of nutrition-related risk are defined: i) major risk (NRI<83.5); 
ii) moderate risk (NRI 83.5-97.5); iii) mild risk (NRI 97.5-100); iv) No 
risk (NRI > 100). The NRI cut-off values are determined according to 
weight losses of 5%, 10% or 20%].
PG-SGA: It is a modification of an earlier tool called SGA. It 
has two sections: a patient-completed section which includes data 
regarding weight history, symptoms, dietary intake and activity level; 
and a section completed by the healthcare professional, who evaluates 
metabolic demand considers disease in relation to nutritional 
requirements and incorporates a physical assessment [41].
EORTC QLQ-C30: It is a questionnaire developed to assess the 
quality of life of cancer patients. It is supplemented by disease-specific 
modules for e.g. Breast, Lung, Head & Neck, Esophageal, Ovarian, 
Gastric, Cervical cancer, Multiple Myeloma, Oesophago-Gastric, 
Prostate, Colorectal Liver Metastases, Colorectal and Brain cancer 
[42].
ECOG performance status scale: It is used by doctors and 
researchers to assess how a patient’s disease is progressing, assess 
how the disease affects the daily living abilities of the patient, and 
determine appropriate treatment and prognosis [43].
 SF-36: The SF-36 is a measure of health status and is commonly 
used in health economics as a variable in the quality-adjusted life year 
calculation to determine the cost-effectiveness of a health treatment. 
It consists of eight scaled scores, which are the weighted sums of the 
questions in their section. Each scale is directly transformed into 
a 0-100 scale on the assumption that each question carries equal 
weight. The eight sections are vitality, physical functioning, bodily 
pain, general health perceptions, physical role functioning, emotional 
role functioning, social role functioning, mental health [44].
Nutrition Assessment
Anthropometric assessment
Anthropometric measurements such as patient’s height, weight, 
and body mass index are considered relevant and objective measures 
of a cancer patient’s nutritional status with few potential errors in 
measurement in a clinical setting. Body weight and weight history 
are essential components of the initial nutritional assessment due to 
the significant impact of weight loss and underweight on morbidity 
and mortality. 
Other parameters such as skinfold (TSF), circumference 
measurements (MUAC, MUAMC) and bioelectrical impedance 
technology for measuring body composition have been used in 
clinical settings to measure lean body mass and body fat  distribution. 
However, these methods suffer from errors due to measurement, 
unless performed by well-trained clinical staff and do not provide 
meaningful data of efficacy on nutritional therapy [45].
Biochemical assessment
Several biochemical parameters such as haemoglobin, fasting 
blood sugar, albumin, transferrin, total blood count, lymphocytes, 
creatinine, serum urea and certain tumor markers such as TNF-α, 
IL-6, p53, NF-κB, etc can be used to determine the nutritional status 
and prognosis of the disease [45].
Dietary assessment
A detailed dietary assessment is indicative of the actual food and 
nutrient intake of the patients which helps the nutritionist/clinician to 
provide individualized nutrition care to improve the nutrition status 
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or ameliorate the effects of cancer therapy. It also gives information 
on malnutrition associated with reduced food intake. 
The dietary intake of cancer patients has to be assessed frequently 
ie., random, weekly, 2 weekdays + 1 weekend day, 24-h dietary recalls 
(gold standard for collecting dietary data) using a five-step multipass 
procedure. Nutritional history should include habitual diet and any 
change in diet pattern, frequency of meals or snacks, quantity of food 
at meals, self-imposed food restrictions, use of supplements, and 
other complementary therapies and vitamin/ mineral use [45].
Functional assessment
In addition to more objective measurements by speech-
language pathologists, the M.D. Anderson Dysphagia Inventory 
(MDADI) measures the impact of dysphagia on QoL with regard to 
social function and is known to have greater degree in identifying 
swallowing-related disability in patients with HNC [46].
Nutrition Support
Evidence suggests that, the nutritional and non-nutritional 
components in the diet reduce initiation and promotion of 
malignant growth. Diets are often deficient in micro nutrients such 
as β-carotene, vitamin A, riboflavin, folic acid, vitamin C, iron, zinc 
and selenium, which are claimed to be potent protective agents that 
act by suppressing carcinogenesis [47]. Research studies confirm 
that in patients undergoing cancer treatment, the mean nutrient 
intake and percent adequacy for all nutrients were much lower than 
the RDA because of swallowing difficulty and treatment associated 
complications [47].
Routes of Intervention
Oral intake
The preferred method of nutrition intervention, the least 
expensive and least invasive, is a standard or modified diet plus oral 
supplementation. Several options of commercial and homemade 
recipes are recommended as tolerated and/or preferred by the patients. 
Several pharmacological and non-pharmacological strategies to 
improve appetite and nutritional intake and prevent early satiety are 
developed with individual patients. However, if patients are unable 
to consume sufficient protein and calories for greater than 7-10 days 
with continued decline in nutritional status as indicated by serum 
hepatic proteins, weight loss, and anthropometrics, alternate means 
of support via enteral nutrition (EN) or total parenteral nutrition 
(TPN) may be indicated [48].
Tube feeding
Evidence suggests that early introduction of tube feeding in 
patients unable to manage sufficient dietary intake will ensure 
nutrition support and may prevent weight loss.
EN: When nutrition management symptoms cannot be 
adequately managed to allow for oral intake sufficient to meet dietary 
requirements, enteral feedings are highly effective in increasing 
energy, protein and micronutrient intake and maintaining body 
weight compared with dietary intake alone. Currently, there are no 
universally accepted guidelines identifying patients who require tube 
feeding [4]. The literature, however, identifies EN procedures such 
as Surgically Inserted Gastrostomy (SIG), Percutaneous Endoscopic 
Gastrostomy (PEG), Radiologically Inserted Gastrostomy (RIG) 
and Nasogastric (NG) tube feeding methods for HNC. Supporting 
evidence favors PEG than other EN procedures viz., RIG, SIG and 
NG with respect to the rates of serious complications and deaths, the 
only drawback being the cost and duration of enteral feeding [49-53]. 
TPN: It is beneficial in severely malnourished and metastatic 
cancer patients. TPN is composed of dextrose, amino acids and lipid 
emulsion at different concentrations. 
In a study on the nutritional and metabolic effects of TPN and 
EN in cachectic cancer patients, an optimum nutritional support 
with TPN providing energy at 35 to 55 kcal/ kg and 1.2 to 2.0 g of 
amino acids/kg daily was beneficial in stimulating whole body protein 
synthesis, increase in thyroxin-binding prealbumin and retinol-
binding protein; decrease skeletal muscle protein catabolism with an 
improvement in lean body mass and visceral proteins whereas EN 
providing energy at 35 kcal/kg and 1.3 g of amino acids/kg improved 
lean body mass and visceral proteins and at least 42 kcal/kg and 2.3 g 
of amino acids/kg improved some immune responses [54].
Three randomized studies were performed to compare TPN and 
EN, and conflicting results were obtained. Only TPN showed some 
significant advantages with regard to weight gain, nitrogen balance, 
maintenance of serum albumin levels and some mineral balances. 
When comparing TPN to a standard oral diet; body weight, nitrogen 
balance, 3-methylhistidine urinary excretion, and serum levels 
of transferrin, cholinesterase, thyroxin-binding prealbumin and 
retinol-binding protein improved with the nutritional support. TPN 
is therefore beneficial to prevent deterioration of nutritional status 
[54].  
Nutrient Requirements
Energy
Malignancies exert a metabolic effect on the host; however, the 
difficulty lies in predicting to what degree metabolic rate is affected 
due to the great variability in individual response as well as type of 
cancer and combination of therapies. Studies have measured the basal 
energy expenditure in a variety of cancer patients.
Squamous cell carcinoma of the head and neck is associated with 
significant weight loss prior to, during, and after cancer diagnosis 
and treatment which needs an effective nutritional intervention using 
appetite stimulants, dietary counseling, and prophylactic enteral tube 
feeding to meet compromised nutritional needs in patients receiving 
radiation and/or chemotherapy [55]. The energy requirements can be 
calculated using Harris benedict equation [56]:
Basal energy expenditure (BEE)
For females: 55(9.6× wt in kg)+ (1.7× ht in cm)- (4.7× age)
For males: 66.5(13.7× wt in kg)+ (5× ht in cm)-(6.8× age)
For weight maintenance needs: BEE×1.15 -1.3
For weight anabolism needs: BEE×1.5
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Daily calories for cancer patients vary between 25 to 35 calories 
per kg body weight (k.b.w) depending on the physical activity i.e, 
whether the patient is bedridden or ambulant.
Carbohydrates
Evidence suggests that reducing the amount of dietary 
carbohydrates (CHOs) could suppress the emergence of cancer 
and proliferation of already existing tumor cells. This hypothesis is 
supported by the association between modern chronic diseases like 
the metabolic syndrome and the risk of developing or dying from 
cancer. Glucose, end product of CHO digestion, can have direct 
and indirect effects on tumor cell proliferation. Most malignant 
cells depend on steady glucose availability in the blood for their 
energy and biomass generating demands and are not able to 
metabolize significant amounts of fatty acids or ketone bodies due to 
mitochondrial dysfunction [57]. There are no recommended dietary 
allowances for carbohydrates in cancer patient populations.
Protein
Protein needs of cancer patients range from 1-1.2 g per k.b.w daily 
for non-stressed patients, 1.2-1.6g per k.b.w daily for hypercatabolic 
cancer patients and 1.5-2.5g per k.b.w daily for severely stressed 
cancer patients. Needs are individualized, and it is best to get specific 
energy and protein needs from a dietician. If energy and protein needs 
are not met, vitamins and minerals will not be absorbable to their full 
potential, as the role of some vitamins is to aid in metabolism [58].
Fats: There are no recommended dietary allowances for lipids 
in cancer patients however, n-3 polyunsaturated fatty acids and 
eicosapentanoic acid are reported to be beneficial in preventing 
weight loss and improve immunity. Anti-cancer effects of coconut oil 
have been reported in the literature, in chemically induced cancers of 
the colon and breast. Coconut oil is reported to be more protective 
than unsaturated oils [59,60].
Vitamins
The need for vitamins and minerals is increased in this patient 
population. Oxidative stress and inflammation contribute to 
several organ toxicities, including neurotoxicities, after common 
cancer chemotherapy regimens. In addition to protein and energy 
malnutrition, patients with HNC may be at risk for vitamin and 
mineral deficiencies. As part of the nutritional management of 
these patients, it is important to replenish protein, energy, vitamin 
and mineral in the required amounts. It is important that patients 
notify their medical team of any medications and vitamin, mineral, 
or herbal supplements they may be taking [61]. Specific vitamins help 
with certain types of cancer. Fat soluble vitamins and vitamin B12 
supplements should be used for people with gallbladder, bile duct 
and pancreas cancer because the absorption for those vitamins may 
be impaired. Liver cancer should be supplemented with fat-soluble 
vitamins and folic acid. Stomach cancer may cause people to have 
trouble absorbing fat; therefore the fat-soluble vitamins should 
be supplemented. Vitamin B12 may also be supplemented, as its 
absorption may be impaired [57].
Nutrition Intervention
The process of nutrition assessment results in nutrition diagnosis. 
The nutrition diagnosis identifies the actual occurrence, the risk, or 
the potential for developing nutrition related problem. Nutritional 
intervention refers to the specific activities required to address 
and correct the nutrition diagnosis. It is designed, planned and 
implemented with the intent of improving the patient’s nutrition 
status. Planning of the intervention requires the input of all disciplines 
[29]. Cancer and its treatment affects the nutritional status of patients 
by altering their metabolic function and reducing their food intake. 
Dietary modifications and supplements are used widely by patients 
with cancer and pre-invasive lesions as an adjunct to standard 
treatment.  International guidelines on the nutritional management 
of patients with cancer recommend intervention with dietary advice 
and/or oral nutritional supplements in patients who are malnourished 
or those judged to be at nutritional risk, but the evidence for these 
recommendations is lacking. Nutritional intervention is significantly 
associated with improvements in energy intake and weight gain, 
some aspects of QoL but do not improve mortality. Nutritional 
intervention studies are limited in India.
Commercial formulation
Commercial formulations for cancer are now available in India, 
which are enriched with eicosapentaenoic acid (EPA) and n-3 
polyunsaturated fatty acid derived from fish oil. In a double blind, 
multi-centric randomized trial, 200 patients with pancreatic cancer 
were supplemented with a high protein, energy dense oral supplement 
enriched with EPA and a control supplement without EPA for eight 
weeks. On an intention-to-treat basis there was no difference between 
the controls and the EPA subjects, with both groups gaining weight. It 
was explained that, this was probably due to inadequate consumption 
of the supplement. Patients in this study only managed a mean 1.4 
servings per day, while patients in the successful pilot study had 
managed 1.9 servings per day. When examined, the results from 
those who had consumed the recommended intake of 1.5-2.0 servings 
of the supplement per day for 8 weeks, it was found that they gained 
more weight (1.21 kg vs. 0.09 kg) and lean body mass (1.46 kg vs. 0.45 
kg) than patients who were taking the oral supplement without EPA 
[62]. This commercial formulation for cancer, might have prevented 
weight loss but the key ingredient EPA being an animal source may 
not be acceptable by all subjects due to socio-cultural practices. 
Cancer patients with a vegetarian food pattern would not want to 
prefer a food formulation enriched with fish oil.  Also, the high cost of 
the formulation will limit its use by the economically weaker patients.
Need for low cost Cancer specific food formulation in India
In the present times, various commercial formulations are 
available for Cancer without regional specificity for different types 
or sites of cancer. A major limiting factor of the commercial tube 
feeding formulations in India is their cost. Therefore, their use is 
limited considering the economic scenario of Indian patients and 
can be used only as a supplement to the blenderized feed. In view 
of the rise in cancer prevalence in the recent decades and associated 
treatment induced malnutrition, there is an urgent need for low cost, 
clinically and metabolically effective food formulations. 
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In India, various studies have been conducted to assess the 
nutritional status of patients with different types of cancers [31,63-
66] which showed a definitive risk of malnutrition in more than 80% 
of the patients. In a pilot study conducted in two cancer hospitals of 
Mysore city, India; to assess the nutritional status and needs of patients 
with HNC, it was found that malnutrition was prevalent among the 
subjects as reflected by somatic parameters (low BMI), Haemoglobin, 
total platelet count. Their nutrient intakes were deficit with respect to 
energy (28%), protein (25%), fat (45%) and carbohydrate (39%) and 
micronutrients intake did not meet the suggested daily intake [67]. 
Therefore, patients with HNC have the highest rate of malnutrition 
due to swallowing problems and effect of treatment. 
Alternative therapy
Researchers are now focusing on medicinal plants with anti-
cancer properties and its use as nutraceuticals. Few commonly 
available Indian medicinal plants such as Tulasi (Ocimum sanctum) 
[68], Cinnamon (Cinnamomum cassia) [69], Custard apple (Annona 
squamosa) [70] and Achyranthes aspera Linn [71] are known to 
possess anti-cancer properties. These plants have proven promising 
effects in reducing tumor progression in animal and cell line models. 
Validation of their effect in vivo is needed.
Conclusion
Cancer is a complex disease with cytokine-induced metabolic 
derangements. Patients with HNC have one of the highest 
malnutrition prevalence rates due to their inability to take food 
orally because of obstruction in the affected area with their diets 
deficit in most of the nutrients. Nutrition Impact Symptoms induced 
by oncological therapies such as Radiotherapy and Chemotherapy 
worsen the nutritional status affecting QoL and functional capacity. 
There is limited literature available on the impact of nutritional 
intervention in improving the nutritional status of patients with HNC 
due to its complex, multifactorial nature. In India, commercially 
available formulations are high in cost and are not disease specific; 
therefore there is a need to formulate a low cost food formulation 
using functional ingredients which could meet the nutritional needs 
and reduce the financial burden of cancer patients in India. 
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